BIOCEUTICALS Arzneimittel Aktiengesellschaft

DEM1201.HRB72513|Stadastr. 2-18, 61118 Bad VilbelGermany|2000

Parent:

Nidda German Topco GmbH

Profit€50.6M

Revenue€131.3M

Balance€111.3M

About

Herstellung, Lizensierung und Weiterentwicklung von Epoetin.

Business purpose (commercial register)

a) die Herstellung, Lizensierung und Weiterentwicklung von Epoetin, insbesondere durch Vergabe von Aufträgen an Dritte, b) die Vornahme aller Geschäfts, die zur Erreichung des Gesellschaftszwecks notwendig oder nützlich erscheinen.

ClassificationWZ 2025

C.21.10.0 - Herstellung von pharmazeutischen Grundstoffen

Business Sectors

Warenlieferungen92.000.000 EUR(75.8%)

Lizenzerträge29.400.000 EUR(24.2%)

Products

Arzneimittel

Opportunities & Risks

US-Markt Kapazitätserweiterung Lieferantenabhängigkeit Lizenzen

Preisdruck Wettbewerbsdruck Regulierung Projektrisiken Zöllen Geopolitische Risiken

This summary was generated with the help of AI. See our Data Quality Notice. Report error?

Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 72513 (as of 11 October 2026)

Company Structure

Shareholders

Name	Type	City
Tim Adolphs	Vorstand	Frankfurt am Main

Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 72513 (as of 11 October 2026)

Financials

Key financial figures over time — BIOCEUTICALS Arzneimittel Aktiengesellschaft
Year	Revenue	Profit	Balance	Employees
2025	€131,330,813	€50,626,409	€111,272,768	—
2024	€121,379,106	€44,505,074	€105,876,313	0
2023	€125,004,468	€47,192,692	€141,254,351	0
2022	€91,825,585	€44,368,814	€107,997,929	0
2021	€88,091,445	€45,536,328	€100,974,163	0
2020	€84,762,890	€40,898,852	€91,197,806	0
2019	€63,065,058	€16,215,596	€86,727,539	0
2018	€63,375,813	€23,435,884	€99,626,803	—
2017	€55,725,759	€20,807,386	€102,341,807	—
2016	€53,189,684	€15,483,557	€94,170,157	—

Source: German Company Register (Unternehmensregister)

Register Files

Current Printout (AD)

Chronological Printout (CD)

Articles of Association

Registration Application

Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 72513 (as of 11 October 2026)

Similar Companies

Torrent Pharma GmbH

Nürnberg · Herstellung von pharmazeutischen Grundstoffen

€648K

Amapharm GmbH

Neunkirchen · Herstellung von pharmazeutischen Grundstoffen

€111.3M

Recordati Pharma GmbH

Ulm · Herstellung von pharmazeutischen Grundstoffen

€108.6M

Annual Financial Statements

Annual Report 2025Published on 11 August 2026

Annual Report 2024Published on 30 July 2025

Annual Report 2023Published on 7 August 2024

Annual Report 2022Published on 11 September 2023

Annual Report 2021Published on 20 September 2022

Annual Report 2020Published on 14 December 2021

Annual Report 2019Published on 28 January 2021

Annual Report 2018Published on 17 December 2019

Consolidated Report 2017Published on 10 September 2018

Annual Report 2017Published on 10 September 2018

Consolidated Report 2016Published on 17 August 2017

Annual Report 2016Published on 14 August 2017

Consolidated Report 2015Published on 16 March 2017

Annual Report 2015Published on 16 March 2017

Annual Report 2014Published on 7 September 2015

Annual Report 2013Published on 4 December 2014

Annual Report 2012Published on 6 February 2014

Annual Report 2011Published on 3 December 2012

Annual Report 2010Published on 16 December 2011

Annual Report 2009Published on 20 December 2010

Annual Report 2008Published on 25 February 2010

Annual Report 2007Published on 9 March 2009

Annual Report 2006Published on 16 January 2008

Source: German Company Register (Unternehmensregister)

Cost type	Amount	Share
Material Costs	€81,944,520	99.2%
Depreciation	€663,685	0.8%
Interest & Similar	€5,391	0.0%

BIOCEUTICALS Arzneimittel Aktiengesellschaft

About

Business purpose (commercial register)

ClassificationWZ 2025

Business Sectors

Products

Opportunities & Risks

Company Structure

Financials

Register Files

Similar Companies

Annual Financial Statements

Cost Distribution (2025)

Trends